Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC4333 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Mononuclear Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Alzehimer’s Disease |
Storage | Liquid Nitrogen |
Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
Human Alzheimer’s Disease Peripheral Blood Mononuclear Cells (PBMCs) are immune cells isolated from the peripheral blood of patients with Alzheimer’s disease (AD), primarily comprising lymphocytes (T cells, B cells, NK cells) and monocytes. Morphologically, PBMCs are typically small, round cells. PBMCs play a critical role in immune regulation and neuroinflammation. AD-associated PBMCs often exhibit abnormal cytokine secretion (e.g., elevated TNF-α, IL-6), and altered T-cell responses, reflecting systemic immune dysfunction linked to AD pathogenesis. These cells are implicated in the peripheral inflammatory cascade that may exacerbate central nervous system pathology, including β-amyloid deposition and tau hyperphosphorylation.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Alzheimer’s Disease Peripheral Blood Mononuclear Cells can be used to study how the peripheral immune system participates in the neurodegenerative process of AD through pathways such as inflammatory factor release and cell migration, especially their role in impaired β-amyloid clearance and neuroinflammation. They can also be used to evaluate the efficacy of anti-inflammatory drugs or immunomodulatory agents.